Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 78

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Clinical Outcomes of TP53 Mutations in Cancers

Robles, Ana I., Jen, Jin, Harris, Curtis C.·2016·Cold Spring Harbor Perspectives in Medicine

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/cshperspect.a026294

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Research works printed but not linked: 118

  1. 10.1038/nature12477 · DOI · Paper page
  2. 10.1093/carcin/bgt411 · DOI
  3. 2012, miR-34—A microRNA replacement therapy is headed to the clinic, Front Genet, 3, 120
  4. 10.1016/j.cmet.2013.06.019 · DOI · Paper page
  5. 10.1126/scitranslmed.3007094 · DOI · Paper page
  6. 2014, TP53 mutants in the tower of babel of cancer progression, Hum Mutat, 35, 689, 10.1002/humu.22514 · DOI
  7. 10.1016/j.cub.2007.06.068 · DOI · Paper page
  8. 10.1038/sj.bjc.6603886 · DOI · Paper page
  9. 10.1186/bcr2811 · DOI
  10. 2015, Tracking sub-clonal TP53 mutated tumor cells in human metastatic renal cell carcinoma, Oncotarget, 5, 19279
  11. 10.3390/ijms140919257 · DOI
  12. 2015, TP53 oncomorphic mutations predict resistance to platinum and taxane-based standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma, Int J Oncol, 46, 607, 10.3892/ijo.2014.2747 · DOI
  13. 10.1073/pnas.88.22.10124 · DOI · Paper page
  14. 10.1038/350429a0 · DOI · Paper page
  15. 10.1158/2159-8290.CD-12-0095 · DOI · Paper page
  16. 2015, Germline TP53 mutations is common in patients with two early-onset primary malignancies, Clin Genet, 87, 499, 10.1111/cge.12480 · doi:10.1111/cge.12480
  17. 10.1002/pbc.24316 · DOI
  18. 10.1073/pnas.1119920109 · DOI · Paper page
  19. 10.1371/journal.pone.0115383 · DOI · Paper page
  20. 10.1016/j.cell.2009.06.048 · DOI · Paper page
  21. 10.1002/hep.26540 · DOI · Paper page
  22. 10.1158/0008-5472.CAN-07-1585 · DOI · Paper page
  23. 2015, Appropriateness of using patient-derived xenograft models for pharmacologic evaluation of novel therapies for esophageal/gastro-esophageal junction cancers, PLoS ONE, 10, e0121872, 10.1371/journal.pone.0121872 · doi:10.1371/journal.pone.0121872
  24. 10.1186/s13058-014-0445-3 · DOI
  25. 10.1093/nar/gku1075 · DOI · Paper page
  26. 2012, Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA, Sci Transl Med, 4, 136ra168
  27. 10.1016/j.cell.2011.12.017 · DOI · Paper page
  28. 10.1136/jmg.2008.058958 · DOI · Paper page
  29. 10.1158/1078-0432.CCR-14-0899 · DOI
  30. 10.1101/cshperspect.a026187 · DOI · Paper page
  31. 2015, Monitoring gastric cancer progression with circulating tumour DNA, Br J Cancer, 112, 352, 10.1038/bjc.2014.609 · DOI
  32. 10.1016/j.cell.2011.02.013 · DOI · Paper page
  33. 10.1016/j.ccr.2007.10.028 · DOI · Paper page
  34. 10.1097/IGC.0b013e31823ca031 · DOI
  35. 10.1126/science.1905840 · DOI · Paper page
  36. 10.1038/ng.2532 · DOI · Paper page
  37. 1995, Mutations of the K-ras and p53 genes in gastric adenocarcinomas from a high-incidence region around Florence, Italy, Cancer Res, 55, 2665
  38. 10.1038/ncomms5706 · DOI
  39. 10.1038/350427a0 · DOI · Paper page
  40. 10.1101/cshperspect.a026146 · DOI · Paper page
  41. 10.1016/S1383-5742(99)00028-9 · DOI · Paper page
  42. 2000, Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: A cancer-prone chronic inflammatory disease, Cancer Res, 60, 3333
  43. 10.1073/pnas.220416097 · DOI · Paper page
  44. 2001, Mutability of p53 hotspot codons to benzo(a)pyrene diol epoxide (BPDE) and the frequency of p53 mutations in nontumorous human lung, Cancer Res, 61, 6350
  45. 10.1038/ng.2922 · DOI · Paper page
  46. 10.1073/pnas.0607286103 · DOI · Paper page
  47. 10.1002/humu.22559 · DOI
  48. 10.1038/nature12634 · DOI · Paper page
  49. 10.1073/pnas.1431692100 · DOI · Paper page
  50. 2012, Molecular therapeutic advances in personalized therapy of melanoma and non-small cell lung cancer, J Pers Med, 2, 35, 10.3390/jpm2020035 · DOI
  51. 10.1038/nrd4236 · DOI · Paper page
  52. 2006, Silent mutations in the gene encoding the p53 protein are preferentially located in conserved amino acid positions and splicing enhancers, Mutat Res, 600, 102, 10.1016/j.mrfmmm.2006.03.004 · DOI
  53. 10.1038/nature12213 · DOI · Paper page
  54. 10.1016/j.cell.2015.02.045 · DOI · Paper page
  55. 10.7326/0003-4819-71-4-747 · DOI · Paper page
  56. 1988, A cancer family syndrome in twenty-four kindreds, Cancer Res, 48, 5358
  57. 2012, Genome-wide studies of the transcriptional regulation by p53, Biochim Biophys Acta, 1819, 684, 10.1016/j.bbagrm.2012.02.002 · DOI
  58. 10.1158/1078-0432.CCR-11-0183 · DOI
  59. 10.1038/onc.2012.299 · DOI
  60. 2015, The genomic landscape of childhood and adolescent melanoma, J Invest Dermatol, 135, 816, 10.1038/jid.2014.425 · DOI · Paper page
  61. 2014, TP53 mutation analysis in clinical practice: Lessons from chronic lymphocytic leukemia, Hum Mutat, 35, 663, 10.1002/humu.22508 · DOI
  62. 10.1038/leu.2014.297 · DOI
  63. 10.1126/science.1978757 · DOI · Paper page
  64. 10.1016/j.febslet.2010.10.005 · DOI · Paper page
  65. 10.1007/s10689-012-9557-z · DOI
  66. 10.1093/jnci/djv193 · DOI
  67. 10.1242/dev.02208 · DOI · Paper page
  68. 10.1093/jnci/djv098 · DOI · Paper page
  69. 10.1093/jnci/djv101 · DOI · Paper page
  70. 10.1073/pnas.1017001108 · DOI · Paper page
  71. 10.1158/1078-0432.CCR-13-2391 · DOI · Paper page
  72. 10.1097/JTO.0000000000000397 · DOI
  73. 10.1002/ijc.26077 · DOI
  74. National Research Council. 2011. Toward precision medicine: Building a knowledge network for biomedical research and a new taxonomy of disease. National Academies Press, Washington, DC.
  75. 10.1038/342705a0 · DOI · Paper page
  76. 10.1158/1078-0432.CCR-05-1029 · DOI · Paper page
  77. 10.1101/cshperspect.a001107 · DOI · Paper page
  78. 2013, Development and characterization of a bladder cancer xenograft model using patient-derived tumor tissue, Cancer Sci, 104, 631, 10.1111/cas.12123 · doi:10.1111/cas.12123
  79. 10.1158/1078-0432.CCR-14-0921 · DOI
  80. 10.1158/1078-0432.CCR-14-2759 · DOI
  81. 10.1056/NEJMoa073770 · DOI · Paper page
  82. 10.1126/scitranslmed.3006086 · DOI · Paper page
  83. 10.1016/j.molcel.2007.05.017 · DOI · Paper page
  84. 10.1016/j.semcancer.2013.12.006 · DOI
  85. 10.1101/cshperspect.a001016 · DOI · Paper page
  86. 10.1182/blood-2013-11-539726 · DOI · Paper page
  87. 10.1093/annonc/mdu288 · DOI · Paper page
  88. 10.1182/blood-2011-08-375758 · DOI · Paper page
  89. 10.1073/pnas.74.12.5463 · DOI · Paper page
  90. 10.1084/jem.20100797 · DOI
  91. 10.1073/pnas.1205457109 · DOI
  92. 10.1038/ng.3252 · DOI · Paper page
  93. 10.1371/journal.pone.0057799 · DOI
  94. 10.1016/j.ccr.2012.11.014 · DOI · Paper page
  95. 10.1073/pnas.1321640111 · DOI · Paper page
  96. 10.1053/j.gastro.2014.04.036 · DOI
  97. 10.1158/1078-0432.CCR-11-2260 · DOI · Paper page
  98. 10.1038/348747a0 · DOI · Paper page
  99. 10.1182/blood-2014-02-558833 · DOI · Paper page
  100. 10.1200/JCO.2014.60.1492 · DOI
  101. 10.1038/onc.2012.586 · DOI
  102. 10.1038/sj.cdd.4401194 · DOI
  103. 10.1016/j.cell.2014.01.051 · DOI · Paper page
  104. 1992, p53 mutations in non-small cell lung cancer in Japan: Association between mutations and smoking, Cancer Res, 52, 734
  105. 10.4161/cc.6.13.4436 · DOI · Paper page
  106. 10.1073/pnas.0707351104 · DOI · Paper page
  107. 10.1158/2159-8290.CD-14-0622 · DOI · Paper page
  108. 2014, Routine use of the Ion Torrent AmpliSeq Cancer Hotspot Panel for identification of clinically actionable somatic mutations, Clin Chem Lab Med, 52, 707
  109. 10.1016/S1470-2045(11)70119-X · DOI · Paper page
  110. 10.1016/j.jhep.2011.03.018 · DOI
  111. 10.1371/journal.pone.0077065 · DOI
  112. 10.1038/ng.3013 · DOI · Paper page
  113. 10.1126/science.1659741 · DOI · Paper page
  114. 10.1038/nrc2584 · DOI · Paper page
  115. 10.1053/j.gastro.2010.11.034 · DOI
  116. 2009, Identification and characterization of a novel germline p53 mutation in a patient with glioblastoma and colon cancer, Int J Cancer, 125, 973, 10.1002/ijc.24432 · DOI
  117. 2015, Germline TP53 mutations in patients with early-onset colorectal cancer in the Colon Cancer Family Registry, JAMA Oncol, 1, 212
  118. 10.1200/JCO.2009.27.8762 · DOI · Paper page

Cited by

See all 78

Metadata

Authors
Robles, A. I., Jen, J., & Harris, C. C.
Venue
Cold Spring Harbor Perspectives in Medicine
Published
2016-07-22
Volume
6
Issue
9
Pages
a026294
ISSN
2157-1422
Cited by
78
References
19
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical Outcomes of TP53 Mutations in Cancers. https://app.cochat.ai/papers/10.1101/cshperspect.a026294
The paper
Robles, A. I., Jen, J., & Harris, C. C. (2016). Clinical Outcomes of TP53 Mutations in Cancers. Cold Spring Harbor Perspectives in Medicine. https://doi.org/10.1101/cshperspect.a026294

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.